In 1998, Cancer incidence rates showed first sustained decline since the National Cancer Institute (NCI) began keeping records…
In 1998, the Mammography Quality Standards Reauthorization Act (MQSA) was passed by the U.S. Congress and continued the…
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
In 1998, Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, was revealed to reduce…
In 1998, The Case Cancer Center (Case CCC) was recognized as an National Cancer Institute (NCI)-designated comprehensive cancer…
On Nov. 26, 1997, the U.S. Food and Drug Administration (FDA) announced it had approved the Monoclonal antibody…
On Aug. 13, 1997, the Stamp Out Breast Cancer Act (PL 105-41) was signed into law by President…
On Jul. 29, 1997, the National Cancer Institute (NCI) released information that nuclear testing during the 1950s could…
On Jul. 23, 1997, Richard D. Klausner, M.D., director of the National Cancer Institute (NCI) announced the creation…
In August 1997, the U.S. Congress passed legislation that directed the U.S. Postal Service to issue its first…
In 1997, Dr. Leland Hartwell became the new President and Director of the Fred Hutchinson Cancer Research Center….
In 1997, the Cancer Genome Anatomy Project (CGAP), created by the National Cancer Institute (NCI), is a multi-year…
In 1997, the National Cancer Institute (NCI) and Chinese scientists found that occupational exposure to benzene is associated…
In 1997, the the University of California, Irvine (UCI) Chao Family Comprehensive Cancer Center (CFCCC) gained NCI designated…
In 1997, the University of Colorado Cancer Center (CU) at the Anschutz Medical Campus received National Cancer Institute…
In 1997, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University received its National Cance Institute ‘comprehensive’…
In 1997, a mouse model of promyelocytic leukemia was developed by Washington University – St. Louis researcher Timothy…
In 1997, planning began for Oregon Health & Science University’s (OHSU) Center for Women’s Health, and an interim…
In 1997, the Oregon Cancer Center was established with a grant from the National Cancer Institute (NCI) of…
In 1997, The Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement would be…
In 1997, Oregon Health & Science University (OHSU) announced that the institute achieved National Cancer Institute (NCI) designation,…
In 1997, the Huntsman Cancer Institute received National Comprehensive Cancer Network (NCCN) designation. In 1995, the Center earned…
In 1997, IsoRay was founded in Richland as a spin-off from the Pacific Northwest National Laboratory (PNNL) to…
On Oct. 2, 1996, SeaMED Corp. was founded in Redmond by Bob Berg. The company manufactured cell-production systems,…
On Jul. 1, 1996, topotecan (Hycamptin), the first of a class of drugs that interferes with the enzyme…
On Jan. 2, 1996, Stanford Medicine researchers announced they had discovered that the p53 protein, known to be…
In June 1996, the Food and Drug Administration (FDA) first approved irinotecan for the treatment of patients with…
In 1996, the American Cancer Society reported that the overall age-adjusted cancer mortality rate declined in each succeeding…
In 1996, Stanford Medicine developmental biologist Matthew Scott and a team at University of California, San Francisco discovered…
In 1996, the National Cervical Cancer Coalition (NCCC), a growing coalition of people battling cervical cancer and HPV…